marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-01-2024
Bausch Health Companies Balance Sheet 2011-2024 | BHC
Annual Balance Sheet Bausch Health Companies
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
21.1 B | 19.8 B | 22.1 B | 23.4 B | 22.7 B | 23.6 B | 24.7 B | 29.3 B | 30.5 B | 14.9 B | 16.8 B | 10.1 B | 6.49 B |
Long Term Debt |
21.9 B | 20.3 B | 22.7 B | 23.9 B | 24.7 B | 24.1 B | 25.2 B | 29.8 B | 30.3 B | 15.3 B | 17.2 B | 10.5 B | 6.54 B |
Long Term Debt Current |
61 M | 50 M | 50 M | 52 M | 53 M | 228 M | 209 M | 1 M | 823 M | 900 K | 205 M | 480 M | 111 M |
Total Non Current Liabilities |
- | - | - | - | 26.5 B | 25.8 B | 27.3 B | 36.7 B | 37.6 B | 18.2 B | 20.2 B | 12.4 B | 8.21 B |
Total Current Liabilities |
4.3 B | 3.94 B | 5.2 B | 4.91 B | 6.25 B | 3.84 B | 4.27 B | 3.61 B | 5.31 B | 2.73 B | 2.51 B | 1.82 B | 924 M |
Total Liabilities |
27.4 B | 25.4 B | 29.2 B | 30.6 B | 32.7 B | 29.7 B | 31.6 B | 40.3 B | 42.9 B | 20.9 B | 22.7 B | 14.2 B | 9.13 B |
Deferred Revenue |
- | - | - | - | - | - | - | 26 M | 16.6 M | 18.8 M | 19.5 M | 7.03 M | 12.8 M |
Retained Earnings |
-9.78 B | -9.19 B | -8.96 B | -8.01 B | -7.45 B | -5.66 B | -2.72 B | -5.13 B | -2.75 B | -2.36 B | -3.28 B | -2.37 B | -2.03 B |
Total Assets |
27.4 B | 25.7 B | 29.2 B | 31.2 B | 33.9 B | 32.5 B | 37.5 B | 43.5 B | 49 B | 26.4 B | 28 B | 18 B | 13.1 B |
Cash and Cash Equivalents |
947 M | 564 M | 582 M | 605 M | 3.24 B | 721 M | 720 M | 542 M | 597 M | 323 M | 600 M | 916 M | 164 M |
Book Value |
-82 M | 260 M | -34 M | 605 M | 1.14 B | 2.82 B | 5.94 B | 3.26 B | 6.03 B | 5.43 B | 5.23 B | 3.72 B | 4.01 B |
Total Shareholders Equity |
-1.02 B | -692 M | -34 M | 605 M | 1.06 B | 2.73 B | 5.85 B | 3.15 B | 5.91 B | 5.31 B | 5.12 B | 3.72 B | 3.93 B |
All numbers in USD currency
Quarterly Balance Sheet Bausch Health Companies
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
21.2 B | 21.5 B | 21.9 B | 21.9 B | 20.1 B | 20.2 B | 20.3 B | 20.8 B | 21.7 B | 23.2 B | 22.7 B | 22.4 B | 23.4 B | 22.7 B | 23.9 B | 23.9 B | 23.9 B | 23.9 B | 24.7 B | 24.7 B | 24.7 B | 24.7 B | 24.1 B | 24.1 B | 24.1 B | 24.1 B | 25.2 B | 25.2 B | 25.2 B | 25.2 B | 29.8 B | 29.8 B | 29.8 B | 29.8 B | 30.3 B | 30.3 B | 30.3 B | 30.3 B | 15.2 B | 15.2 B | 15.2 B | 15.3 B | 17.2 B | 17.2 B | 17.2 B | 17.2 B | 10.5 B | 10.5 B | 10.5 B | 10.5 B | 6.54 B | 6.54 B | 6.54 B | 6.54 B |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
26.7 B | 27.1 B | 27.4 B | 27.3 B | 25.2 B | 25.3 B | 25.4 B | 25.9 B | 27.9 B | 29.2 B | 29.2 B | 29.4 B | 30.7 B | 29.2 B | 30.6 B | 30.6 B | 30.6 B | 30.6 B | 32.7 B | 32.7 B | 32.7 B | 32.7 B | 29.7 B | 29.7 B | 29.7 B | 29.7 B | 31.6 B | 31.6 B | 31.6 B | 31.6 B | 40.3 B | 40.3 B | 40.3 B | 40.3 B | 42.9 B | 42.9 B | 42.9 B | 42.9 B | 20.9 B | 20.9 B | 20.9 B | 20.9 B | 22.7 B | 22.7 B | 22.7 B | 22.7 B | 14.2 B | 14.2 B | 14.2 B | 14.2 B | 9.18 B | 9.13 B | 9.13 B | 9.13 B |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7.03 M | 18.1 M | 7.03 M | 8.73 M | 12.8 M | 12.8 M | 12.8 M | 12.8 M |
Retained Earnings |
-9.83 B | -9.84 B | -9.78 B | -9.74 B | -9.36 B | -9.39 B | -9.19 B | -8.78 B | -9.18 B | -9.03 B | -8.96 B | -9.03 B | -9.22 B | -8.96 B | -8.01 B | -8.01 B | -8.01 B | -8.01 B | -7.45 B | -7.45 B | -7.45 B | -7.45 B | -5.66 B | -5.66 B | -5.66 B | -5.66 B | -2.72 B | -2.72 B | -2.72 B | -2.72 B | -5.13 B | -5.13 B | -5.13 B | -5.13 B | -2.75 B | -2.75 B | -2.75 B | -2.75 B | -2.4 B | -2.36 B | -2.36 B | -2.36 B | -3.28 B | -3.28 B | -3.28 B | -3.28 B | -2.37 B | -2.37 B | -2.37 B | -2.37 B | -2.03 B | -2.03 B | -2.03 B | -2.03 B |
Total Assets |
26.5 B | 26.9 B | 27.4 B | 27.1 B | 25.5 B | 25.4 B | 25.7 B | 26.3 B | 28.2 B | 29.1 B | 29.2 B | 29.3 B | 30 B | 29.2 B | 31.2 B | 31.2 B | 31.2 B | 31.2 B | 33.9 B | 33.9 B | 33.9 B | 33.9 B | 32.5 B | 32.5 B | 32.5 B | 32.5 B | 37.5 B | 37.5 B | 37.5 B | 37.5 B | 43.5 B | 43.5 B | 43.5 B | 43.5 B | 49 B | 49 B | 49 B | 49 B | 26.3 B | 26.3 B | 26.3 B | 26.4 B | 27.9 B | 28 B | 28 B | 28 B | 18 B | 18 B | 18 B | 18 B | 13.1 B | 13.1 B | 13.1 B | 13.1 B |
Cash and Cash Equivalents |
595 M | 733 M | 947 M | 760 M | 579 M | 518 M | 564 M | 486 M | 659 M | 1.25 B | 582 M | 690 M | 642 M | 582 M | 1.82 B | 605 M | 605 M | 605 M | 3.24 B | 3.24 B | 3.24 B | 3.24 B | 721 M | 721 M | 721 M | 721 M | 720 M | 720 M | 720 M | 720 M | 542 M | 542 M | 542 M | 542 M | 597 M | 597 M | 597 M | 597 M | 323 M | 323 M | 323 M | 323 M | 600 M | 600 M | 600 M | 600 M | 916 M | 916 M | 916 M | 916 M | 164 M | 164 M | 164 M | 164 M |
Book Value |
-227 M | -174 M | -82 M | -235 M | 271 M | 145 M | 260 M | 433 M | 253 M | -141 M | -34 M | -135 M | -611 M | -34 M | 605 M | 605 M | 605 M | 605 M | 1.14 B | 1.14 B | 1.14 B | 1.14 B | 2.82 B | 2.82 B | 2.82 B | 2.82 B | 5.94 B | 5.94 B | 5.94 B | 5.94 B | 3.26 B | 3.26 B | 3.26 B | 3.26 B | 6.03 B | 6.03 B | 6.03 B | 6.03 B | 5.4 B | 5.43 B | 5.43 B | 5.43 B | 5.2 B | 5.23 B | 5.23 B | 5.23 B | 3.72 B | 3.72 B | 3.72 B | 3.72 B | 3.93 B | 4.01 B | 4.01 B | 4.01 B |
Total Shareholders Equity |
-1.18 B | -1.12 B | -1.02 B | -1.18 B | 271 M | 145 M | -692 M | 433 M | 253 M | -141 M | -106 M | -135 M | -611 M | -124 M | 605 M | 535 M | 535 M | 535 M | 1.06 B | 1.06 B | 1.06 B | 1.06 B | 2.73 B | 2.73 B | 2.73 B | 2.73 B | 5.85 B | 5.85 B | 5.85 B | 5.85 B | 3.15 B | 3.15 B | 3.15 B | 3.15 B | 5.91 B | 5.91 B | 5.91 B | 5.91 B | 5.28 B | 5.31 B | 5.31 B | 5.31 B | 5.12 B | 5.12 B | 5.12 B | 5.12 B | 3.72 B | 3.72 B | 3.72 B | 3.72 B | 3.93 B | 4.01 B | 4.01 B | 4.01 B |
All numbers in USD currency